Comments
Loading...
Matinas BioPharma Hldgs (AMEX:MTNB) Stock, Earnings Estimates, EPS, And Revenue
Matinas BioPharma Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 26
EPS Estimate
$-0.780
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Matinas BioPharma Hldgs using advanced sorting and filters.
Data brought to you by Benzinga APIs
Matinas BioPharma Hldgs (MTNB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.85 | $-1.00 | 15.0 % |
| Q2 | 2024-08-14 | $-1.00 | $-1.00 | 0.00 % |
| Q1 | 2024-05-09 | $-1.50 | $-1.50 | 0.00 % |
| Q4 | 2024-03-27 | $-1.50 | $0 | -100.0 % |
Matinas BioPharma Hldgs (MTNB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2023-05-10 | $1.10M | $300.00K | 265.3 % |
| Q4 | 2023-03-15 | $1.06M | $1.10M | -3.36 % |
| Q3 | 2022-11-02 | $0 | $830.00K | -100.0 % |
| Q2 | 2022-08-11 | $1.06M | $100.00K | 963.0 % |
FAQ
When is Matinas BioPharma Hldgs (AMEX:MTNB) reporting earnings?
Matinas BioPharma Hldgs (MTNB) is scheduled to report earnings on March 26, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Matinas BioPharma Hldgs (AMEX:MTNB)?
The Actual EPS was $-0.85, which beat the estimate of $-1.00.
What were Matinas BioPharma Hldgs’s (AMEX:MTNB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.